These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 24600033)

  • 1. Siglec-G deficiency leads to more severe collagen-induced arthritis and earlier onset of lupus-like symptoms in MRL/lpr mice.
    Bökers S; Urbat A; Daniel C; Amann K; Smith KG; Espéli M; Nitschke L
    J Immunol; 2014 Apr; 192(7):2994-3002. PubMed ID: 24600033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Siglec-G Deficiency Leads to Autoimmunity in Aging C57BL/6 Mice.
    Müller J; Lunz B; Schwab I; Acs A; Nimmerjahn F; Daniel C; Nitschke L
    J Immunol; 2015 Jul; 195(1):51-60. PubMed ID: 25987743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD22 x Siglec-G double-deficient mice have massively increased B1 cell numbers and develop systemic autoimmunity.
    Jellusova J; Wellmann U; Amann K; Winkler TH; Nitschke L
    J Immunol; 2010 Apr; 184(7):3618-27. PubMed ID: 20200274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM; Stanley ER; Kelley VR
    J Immunol; 2004 Oct; 173(7):4744-54. PubMed ID: 15383612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central and multiple roles of B cells in lupus pathogenesis.
    Chan OT; Madaio MP; Shlomchik MJ
    Immunol Rev; 1999 Jun; 169():107-21. PubMed ID: 10450512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C; Zhao ML; Scearce RM; Diaz M
    Arthritis Rheum; 2011 Apr; 63(4):1086-96. PubMed ID: 21225690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA; Glynn E; Garcia SJ; Panzenbeck M; Pelletier J; Dimock J; Seccareccia E; Bosanac T; Khalil S; Harcken C; Webb D; Nabozny G; Fine JS; Souza D; Klein E; Herlitz L; Ramanujam M; Putterman C
    Clin Immunol; 2018 Dec; 197():205-218. PubMed ID: 30339790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease Stage-Specific Pathogenicity of CD138 (Syndecan 1)-Expressing T Cells in Systemic Lupus Erythematosus.
    Liu L; Takeda K; Akkoyunlu M
    Front Immunol; 2020; 11():1569. PubMed ID: 32849532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autoantibody responses and pathology regulated by B7-1 and B7-2 costimulation in MRL/lpr lupus.
    Liang B; Kashgarian MJ; Sharpe AH; Mamula MJ
    J Immunol; 2000 Sep; 165(6):3436-43. PubMed ID: 10975864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced lymphoproliferation and diminished autoimmunity in CD4-deficient MRL/lpr mice.
    Chesnutt MS; Finck BK; Killeen N; Connolly MK; Goodman H; Wofsy D
    Clin Immunol Immunopathol; 1998 Apr; 87(1):23-32. PubMed ID: 9576007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM; Turner JE; Paust HJ; Lindner M; Peters A; Heiss K; Velden J; Hopfer H; Fehr S; Krieger T; Meyer-Schwesinger C; Meyer TN; Helmchen U; Mittrücker HW; Stahl RA; Panzer U
    J Immunol; 2009 Oct; 183(7):4693-704. PubMed ID: 19734217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deficient leptin signaling ameliorates systemic lupus erythematosus lesions in MRL/Mp-Fas lpr mice.
    Fujita Y; Fujii T; Mimori T; Sato T; Nakamura T; Iwao H; Nakajima A; Miki M; Sakai T; Kawanami T; Tanaka M; Masaki Y; Fukushima T; Okazaki T; Umehara H
    J Immunol; 2014 Feb; 192(3):979-84. PubMed ID: 24391210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C1q deficiency and autoimmunity: the effects of genetic background on disease expression.
    Mitchell DA; Pickering MC; Warren J; Fossati-Jimack L; Cortes-Hernandez J; Cook HT; Botto M; Walport MJ
    J Immunol; 2002 Mar; 168(5):2538-43. PubMed ID: 11859149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Terminal deoxynucleotidyl transferase deficiency decreases autoimmune disease in MRL-Fas(lpr) mice.
    Feeney AJ; Lawson BR; Kono DH; Theofilopoulos AN
    J Immunol; 2001 Sep; 167(6):3486-93. PubMed ID: 11544342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-21 has a pathogenic role in a lupus-prone mouse model and its blockade with IL-21R.Fc reduces disease progression.
    Herber D; Brown TP; Liang S; Young DA; Collins M; Dunussi-Joannopoulos K
    J Immunol; 2007 Mar; 178(6):3822-30. PubMed ID: 17339481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of EZH2 Ameliorates Lupus-Like Disease in MRL/lpr Mice.
    Rohraff DM; He Y; Farkash EA; Schonfeld M; Tsou PS; Sawalha AH
    Arthritis Rheumatol; 2019 Oct; 71(10):1681-1690. PubMed ID: 31106974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of natural autoantibodies in MRL-lpr mice protects from lupus nephritis and improves survival.
    Mannoor K; Matejuk A; Xu Y; Beardall M; Chen C
    J Immunol; 2012 Apr; 188(8):3628-38. PubMed ID: 22407922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity.
    Chan OT; Madaio MP; Shlomchik MJ
    J Immunol; 1999 Oct; 163(7):3592-6. PubMed ID: 10490951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.